Back to mobile site

UPDATE: BMO Capital Starts Y-mAbs Therapeutics (YMAB) at Outperform

June 23, 2022 4:01 PM EDT Send to a Friend
(Updated - June 23, 2022 4:02 PM EDT)

BMO Capital analyst Etzer Darout initiates coverage on Y-mAbs Therapeutics (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login